Chicago, IL, United States of America

Todd N Soltwedel

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 12.9

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Todd N Soltwedel: Innovator in Pharmaceutical Compounds

Introduction

Todd N Soltwedel is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various health conditions. With a total of 4 patents to his name, Soltwedel's work has the potential to impact the treatment of several diseases.

Latest Patents

Among his latest patents, Soltwedel has developed pyridinone and pyridazinone derivatives. These compounds are designed to be useful as agents in the treatment of diseases and conditions, including inflammatory diseases, diabetes, obesity, cancer, and AIDS. Additionally, he has patented anti-viral compounds that are effective in inhibiting the replication of the Hepatitis C virus (HCV). This invention also encompasses processes for making such compounds, compositions that include them, and methods for using these compounds to treat HCV infection.

Career Highlights

Throughout his career, Todd N Soltwedel has worked with prominent companies in the pharmaceutical industry, including AbbVie Inc. and Abbott Laboratories Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Soltwedel has collaborated with several professionals in his field, including David A DeGoey and Pamela L Donner. These partnerships have likely enhanced his research and development efforts.

Conclusion

Todd N Soltwedel is a distinguished inventor whose work in pharmaceutical compounds has the potential to make a significant impact on healthcare. His innovative contributions continue to advance the treatment options available for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…